^
BIOMARKER:

PD-L1 underexpression

i
Other names: PD-L1, CD274, HPD-L1, PD-L1, B7H1, PDL1, Programmed death ligand 1, B7-H1, B7-H, PDCD1L1, PDCD1LG1, PDCD1 Ligand 1, B7 homolog 1, CD274 Antigen, Programmed cell death 1 ligand 1, CD274 molecule




Show legend
Non Small Cell Lung Cancer
Squamous Cell Carcinoma of Head and Neck
Melanoma
Lung Adenocarcinoma
Lung Non-Small Cell Squamous Cancer
Esophageal Squamous Cell Carcinoma
Urothelial Cancer
HER2 Positive Breast Cancer
Triple Negative Breast Cancer
Gastric Adenocarcinoma
Hepatocellular Cancer
Cutaneous T-cell Lymphoma
Esophageal Cancer
Colorectal Cancer
Acute Myelogenous Leukemia
Solid Tumor
Lung Non-Squamous Non-Small Cell Cancer
Renal Cell Carcinoma
Malignant Pleural Mesothelioma
Esophageal Adenocarcinoma
Mantle Cell Lymphoma
pembrolizumab
atezolizumab + RG6180
nivolumab + ipilimumab
fam-trastuzumab deruxtecan-nxki
durvalumab + tremelimumab
toripalimab-tpzi + surufatinib
camrelizumab
aglatimagene besadenovec
nivolumab/relatlimab
nivolumab
ipilimumab + cemiplimab-rwlc
nivolumab + IPI-549
durvalumab + lenalidomide
XmAb14045
cetuximab sarotalocan
avelumab + VX15
gemcitabine
pembrolizumab + VX15
MEDI5752
pembrolizumab + DS-1062a
enfortumab vedotin-ejfv
pembrolizumab + OBT076
bevacizumab
ipilimumab
durvalumab
carboplatin + paclitaxel
ibrutinib
Immunotherapy
PD1 inhibitor
PD-L1 inhibitor